Simplify Medical

Founded in 2013 and based in California, US, Simplify Medical, Inc. is a medical company focused on cervical spinal disc arthroplasty using MRI-compatible materials designed to optimize diagnostic imaging and reduce ionizing radiation. In 2018, Simplify Medical, Inc. In 2021, NuVasive, Inc. acquired Simplify Medical for USD 150 million to expand its cervical spine technology portfolio. In 2021, MCRA, LLC, a medical device and biologics advisory firm announced the successful management and execution of the company’s two clinical studies and approval by the US FDA for the Simplify Cervical Artificial Disc to be used at one-level and two contiguous levels in the cervical spine. Simplify Medical develops Simplify® Cervical Artificial Disc (Simplify Disc) for cervical total disc replacements (cTDR) which are indicated for use in patients with intractable radiculopathy with or without neck pain, or myelopathy, at one or two contiguous cervical levels (C3-C7). The Simplify Disc has features such as anatomic designs to fit patient anatomy, protect faucets, and prevent overstuffing; physiologic motions; and radiologic design for detailed anatomic visualization on MR Imaging. The anatomic disc heights ranged from 4mm, 5mm, and 6mm whereas the three-piece design permits 12-degree flexion/extension, lateral bending, and axial rotation. The disc is composed of two PEEK endplates coated with titanium plasma spray and a ceramic core for optimizing biocompatibility for a lifetime implant. The surgical procedure comprises three steps: disc sizing, slot cutting, and disc placement. NuVasive Inc along with Simplify Medical plans to expand the use of the device to 2-level indications.

1. Series B

   Feb 9, 2018

   Amount

   $23M

   Investors

   Locked

2. Series B

   Jul 19, 2017

   Amount

   $21M

   Investors

   Locked